Showing 131-140 of 325 grants

Title Institution Researcher Program Duration Total Award Amount
Transcriptional modulation by BET bromodomain inhibitors in beta cells The Medical College of Wisconsin Inc. Joshua Nord Cures 01-March-2023 to 28-February-2026 $221,638.00
Defining the cell surface glycoproteome and glycome of human islets to enable single cell analysis of human β-cells The Medical College of Wisconsin Inc. John Corbett Cures 01-October-2022 to 30-June-2026 $750,000.00
Expanding Access to T1D Care through the PEN-Plus Strategy The Brigham and Women’s Hospital, Inc. Gene Bukhman Mission 01-August-2024 to 31-July-2027 $5,999,961.29
A prodrug system for targeted activation of small molecules in beta cells The Brigham and Women’s Hospital, Inc. Amit Choudhary Cures 01-February-2024 to 31-January-2027 $2,250,000.00
Novel Combination Regimen Therapy to Modulate Pro- and Anti-inflammatory Lipid Signaling to Counter T1D The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-July-2022 to 30-June-2025 $594,999.97
Targeting Prostaglandin F-series Lipids to Counter Beta-Cell-Death and T1D Development The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham Sasanka Ramanadham Cures 01-May-2023 to 30-April-2026 $749,763.00
Implementing Best Practice Advisories to Reduce Inequities in Technology Use for people with Type 1 Diabetes T1D Exchange, Inc. Nicole Rioles Improving Lives 01-May-2024 to 30-April-2027 $1,995,534.06
Research and Data Research T1D Exchange, Inc. Jaime Lucove Transportfolio 01-December-2022 to 30-November-2025 $620,435.07
Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology Syntax Bio, Inc Ryan Clarke Cures 15-November-2025 to 14-November-2027 $856,250.00
Novel insulin formulations for pumps Stanford University Yanxian Zhang Improving Lives 01-March-2023 to 28-February-2026 $243,986.00